MAR vs TRDA · P/E 32, rev $26.19B vs P/E 12, rev $210.8M
Marriott International Inc (MAR) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Marriott International Inc (MAR) is a lodging company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported MAR revenue for 2025-12-31 was $26.19B. Net income was $2.60B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
MAR currently screens at market cap $76.70B and trailing P/E 31.9. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the MAR and TRDA stock pages for the full models.
Not investment advice.